Evidence map›Paper›PMID 33462009›Full record

ArticleBMJ case reports2021

Non-central serous chorioretinopathy in a patient with systemic lupus erythematosus and hydroxychloroquine retinopathy.

Diogo Hipolito-Fernandes, Maria Elisa Luís, Rita Flores, Rita Anjos

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Diogo Hipolito-FernandesOphthalmology, Centro Hospitalar de Lisboa Central EPE, Lisboa, Portugal cdiogo777@gmail.com.ORCID http://orcid.org/0000-0002-5972-4068
Maria Elisa LuísOphthalmology, Centro Hospitalar de Lisboa Central EPE, Lisboa, Portugal.ORCID http://orcid.org/0000-0002-9361-089X
Rita FloresOphthalmology, Centro Hospitalar de Lisboa Central EPE, Lisboa, Portugal.
Rita AnjosOphthalmology, Centro Hospitalar de Lisboa Central EPE, Lisboa, Portugal.
Unidade Local de Saúde de São José · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Subretinal fluid accumulation in a patient with systemic lupus erythematosus (SLE) may represent a diagnostic challenge. We present a case of a 43-year-old man with baseline diagnosis of SLE and hydroxychloroquine-associated maculopathy who reported progressive vision loss on the right eye, associated with corticosteroids use for an arthritic crisis. Ophthalmological examination did not reveal any acute finding. On optical coherence tomography, subretinal fluid in the perifoveal area was visible on the right eye, with corresponding enlargement of the visual field defect. An increased choroidal thickness was also visible. Fluorescein angiography revealed, on the right eye, two pinpoint areas of leakage and indocyanine green angiography signs of choroidal vascular hyperpermeability. Considering a diagnosis of a non-central central serous chorioretinopathy, corticosteroids use was interrupted, with resolution of the subretinal fluid. This case illustrates the relevance of a multimodal imaging approach to guide the diagnosis of patient with an SLE with subretinal fluid.

Indexed as

Adrenal Cortex HormonesAdultAntirheumatic AgentsDisease ProgressionDrug Therapy, CombinationHumansHydroxychloroquineImmunosuppressive AgentsLupus Erythematosus, SystemicMaleRetinal DiseasesAdrenal Cortex HormonesAntirheumatic AgentsHydroxychloroquineImmunosuppressive Agentsmaculaophthalmologyretina

Identifiers

PMID33462009
PMCPMC7813357
OpenAlexW3122426066

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.